前列腺增生动物模型制备规范(草案)  

Specifications for Preparation of Prostatic Hyperplasia Animal Models (Draft)

作　　者：中药实验药理专业委员会 Traditional Chinese Medicine Experimental Pharmacology Professional Committee;China Association of Chinese Medicine

机构地区：[1]中华中医药学会中药实验药理专业委员会

出　　处：《中国实验方剂学杂志》2018年第19期15-19,共5页Chinese Journal of Experimental Traditional Medical Formulae

基　　金：国家“十一五”科技支撑计划项目(2008BAI53B09);国家中医药管理局中医药标准化专项(2017-149-11);国家自然科学基金项目(81173474)

摘　　要：近年来,前列腺增生发病率呈现不断上升的趋势,且越来越年轻化。现有前列腺增生模型多为病理性,且以西医指标为主。在基于前列腺增生模型中西医临床病证特点分析及大量实验研究的基础上,形成了如下前列腺增生动物模型制备规范（草案）。In recent years,the incidence of prostatic hyperplasia shows a rising trend,and the age of onset tends to be younger. Most of the prostatic hyperplasia models are pathological with western medicine as the main indicators. Based on analysis of clinical characteristics of the Chinese and western medicine for prostatic hyperplasia,and a large number of experimental studies,this article forms the following specifications（ draft） for the preparation of prostatic hyperplasia models（ draft）.

关 键 词：前列腺增生 动物模型 规范 草案 丙酸睾酮 性激素 

分 类 号：R24[医药卫生—中医临床基础] R22[医药卫生—中医学]